Bern Human Organoid-Study to Study Host-microbe Interaction
Condition(s) studied
Study summary
The human body inhabits a complex consortium of different microbes which together form the microbiota. Virtually every surface of the human body is colonized by a distinct microbiota, forming complex communities. An increasing number of research results indicates that changes in the microbiota can have vast effects on the health of its host.
Most studies investigating the microbiota were conducted on animals, as many interventions and investigations cannot be performed on humans due to ethical considerations. This raises the question if findings from experimental studies are translational and can benefit patients. That becomes especially apparent when trying to dissect molecular mechanisms involved in this fine-tuned interplay between nutrients, the microbiota, and its host.
By establishing human organoid cultures from the large and small intestine that can be exposed to microbes and/or microbial products with subsequent transcriptomic, epigenetic and immunological analysis, the investigators aim to generate findings with high translational potential with new insights into the complex interaction of the microbiota, the host and its immune system.
Eligibility
Primary outcome measure(s)
- Assessment of changes in the transcriptomic profile of epithelial cells before and after organoid culture — 3 Years
Assessment of changes in the transcriptomic profile of epithelial cells before and after organoid culture is established by RNA-sequencing and quantitative polymerase chain reaction (qPCR) - Assessment of changes in the epigenome of epithelial cells before and after organoid culture — 3 Years
Assessment of changes in the epigenome of epithelial cells before and after organoid culture is established by whole genome bisulphite sequencing and chromatin immunoprecipitation sequencing - Transcriptomic and Epigenomic Landscape of host-microbiota Interaction — 3 Years
Determining effects of microbial-derived metabolites on the transcriptomic and epigenomic landscape of human organoids treated with the respective metabolite - Host-Microbiota interaction - Stem cell maintenance and Cell Differentiation — 3 Years
Determining effects of microbial-derived metabolites on epithelial cell differentiation and stem cell maintenance
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Inselspital, University Hospital Bern | Bern | Switzerland | Recruiting |
More Insel Gruppe AG, University Hospital Bern trials in Switzerland
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05323357 on ClinicalTrials.gov ↗ ← All trials in Switzerland